Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0021 | 0.04 | 1 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0021 | 0.04 | 0.5 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0021 | 0.04 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.04 | 0.0015 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0021 | 0.04 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.04 | 0.0015 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0021 | 0.04 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | taga, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.0021 | 0.04 | 0.5 |
Entamoeba histolytica | P-glyco protein 6, putative | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0021 | 0.04 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0021 | 0.04 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0021 | 0.04 | 1 |
Entamoeba histolytica | P-glycoprotein-1 | 0.0021 | 0.04 | 0.5 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0021 | 0.04 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | abcb9, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0021 | 0.04 | 1 |
Schistosoma mansoni | smdr2 | 0.0021 | 0.04 | 0.5 |
Onchocerca volvulus | 0.0021 | 0.04 | 0.5 | |
Entamoeba histolytica | P-glycoprotein-2, putative | 0.0021 | 0.04 | 0.5 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0021 | 0.04 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0021 | 0.04 | 0.5 |
Leishmania major | p-glycoprotein | 0.0021 | 0.04 | 0.5 |
Entamoeba histolytica | P-glycoprotein-5 | 0.0021 | 0.04 | 0.5 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0021 | 0.04 | 0.0015 |
Brugia malayi | multidrug resistance protein 3 | 0.0021 | 0.04 | 0.5 |
Brugia malayi | ABC transporter family protein | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0021 | 0.04 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0021 | 0.04 | 0.5 |
Entamoeba histolytica | P-glycoprotein 5, putative | 0.0021 | 0.04 | 0.5 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.0176 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0021 | 0.04 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0021 | 0.04 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0021 | 0.04 | 1 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0021 | 0.04 | 0.0015 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0021 | 0.0386 | 0.9639 |
Toxoplasma gondii | hypothetical protein | 0.0176 | 1 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0021 | 0.04 | 1 |
Entamoeba histolytica | P-glycoprotein-2 | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0021 | 0.04 | 1 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0021 | 0.0386 | 0.9639 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0021 | 0.04 | 0.5 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0021 | 0.04 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.